Insights into pharmacogenomics and its impact upon immunosuppressive therapy (Q34786114)

4 August 2017

1 reference

title

Insights into pharmacogenomics and its impact upon immunosuppressive therapy (English)

1 reference

4 August 2017

1 reference

Yoram Yagil

1

1 reference

4 August 2017

Chana Yagil

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

4 August 2017

published in

Transplant Immunology

1 reference

4 August 2017

volume

9

1 reference

4 August 2017

issue

2-4

1 reference

4 August 2017

page(s)

203-209

1 reference

Human Genome Project and pharmacogenomics--implications for pharmacy

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: opening new vistas in pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: worthy of pharmacy's attention

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Inventing the pharmacogenomics business

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: the next logical step

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics--teaching old drugs new tricks.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: will it change the field of medicine?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics - it's not just pharmacogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics, pharmacogenomics, and pharmacobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics and pharmacogenomics.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics and pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Advances in pharmacogenetics and pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics to predict drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: the inherited basis for interindividual differences in drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics and pharmacogenomics: using genetic information to guide therapeutic decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenetics and pharmacogenomics: tailored drug therapy for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: the genomics of drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: unlocking the human genome for better drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

The genomic revolution: is the real risk under-investment rather than bankrupt health care systems?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Projecting future drug expenditures--2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Impact of pharmacogenomics on the clinical laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Preparing for the revolution--pharmacogenomics and the clinical lab

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Pharmacogenomics: implications for laboratory medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Impact of genomics on drug discovery and clinical medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Can pharmacogenomics make a difference in drug development?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Current pharmacogenomic approaches to clinical drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Clinical pharmacogenomics: applications in pharmaceutical R&D

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

3D-1D threading methods for protein fold recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Automated protein modelling--the proteome in 3D.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Mining for SNPs: putting the common variants--common disease hypothesis to the test

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

New collaborations make pharmacogenomics a SNP

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Large-scale SNP scoring from unamplified genomic DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Discovery, scoring and utilization of human single nucleotide polymorphisms: a multidisciplinary problem

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

The use of single-nucleotide polymorphism maps in pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

The use of single nucleotide polymorphisms in the isolation of common disease genes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

A novel procedure for efficient genotyping of single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

High throughput analysis of differential gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

DNA chips: a new tool for genetic analysis and diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Expression databases--resources for pharmacogenomic R&D.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Applications of biochip and microarray systems in pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarrays. 22-24 January 2001, Zurich, Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

High-throughput genotyping assay approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Cluster analysis and promoter modelling as bioinformatics tools for the identification of target genes from expression array data

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Gene expression analysis as an aid to the identification of drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Myocardial revascularisation: the search for the holy grail

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

The human genome project: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Ethical considerations in clinical pharmacogenomics research

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

Ethical and legal implications of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900022-9

7 January 2021

10.1016/S0966-3274(02)00022-9

Identifiers

DOI

1 reference

4 August 2017

1 reference